Feasibility Studies to Inform the Design of Future Clinical Trials
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Institutes of Health plans to issue a Notice of Funding Opportunity aimed at soliciting applications for feasibility studies that will support the design and conduct of future definitive clinical trials. These studies are intended to address critical aspects such as recruitment, randomization, retention, intervention delivery, data collection, adherence, acceptability, and intervention protocol development or adaptation. The goal is to ensure the future trials are methodologically rigorous and reproducible, ultimately leading to clinical trials with significant public health impact. The focus includes a range of trial types, such as efficacy, effectiveness, pragmatic, dissemination and implementation, and phase/stage II or later trials. At present, applications are not being accepted; this announcement serves to give prospective applicants adequate time to form collaborations and develop well-constructed proposals. Researchers with expertise in clinical trial planning, design, implementation, intervention development, and stakeholder engagement are encouraged to prepare for submission when the NOFO is officially released. The funding opportunity is under the Department of Health and Human Services through the NIH, with contact available via the NCCIH Division of Extramural Research for further information.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
The National Institutes of Health intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications that propose feasibility studies that could inform the design and conduct of subsequent definitive clinical trials (e.g., efficacy, effectiveness, pragmatic, dissemination and implementation, phase/stage II or later trials). Applications to this NOFO should demonstrate that the proposed feasibility research is scientifically necessary to design or plan the subsequent definitive clinical trial. Studies may utilize mixed methods and feasibility clinical trials to assess feasibility of recruitment, randomization, retention, intervention delivery, data collection, adherence, acceptability, and/or develop or adapt intervention components or protocols. The proposed feasibility research should enhance the rigor and reproducibility of the future trial methods. The subsequent definitive clinical trial should have the potential to make a significant impact on public health.
Applications are not being solicited at this time. This notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. Investigators with expertise in clinical trial planning, design, implementation, intervention development, and/or stakeholder engagement are encouraged to begin to consider applying for this new NOFO.
